润诚领航基金成功投资世界级人工智能企业“依

 新闻资讯     |      2020-03-25 13:38

?? ? 在万众一心,共同抗击新冠疫情的特殊时期,走上前线的是逆行英雄;在后方坚守岗位,做好本职工作也是担当。近日,华润资本与诚通香港共同发起设立的“润诚产业领航基金”克服种种不期而至的困难,顺利完成对世界级人工智能企业“依图科技”三千万美元的投资。此后,基金将继续推动企业与华润集团、中国诚通两大央企深入对接产业,助力企业将世界级原创科技产业化、规模化,以科技支撑打赢疫情防控阻击战。

? ? 依图是一家完全基于我国自主研发技术成长起来的世界级人工智能企业,系国家新一代人工智能开发创新平台和上海市医疗图像与医学知识图谱人工智能重点实验室建设单位;利用计算机视觉、自然语言学习、语音识别和芯片设计开发等软硬件技术,提供各应用场景下的综合人工智能解决方案。作为人工智能领域创新的先驱之一,依图将先进的人工智能技术与公共安全、医疗保健、金融、零售和芯片开发行业的工业应用相结合,得到各行各业使用者的广泛赞誉。

? ? 依图技术能力突出,在国际国内各项专业权威竞赛中屡获第一。2018年,依图与华西医院联合发布肺癌临床科研智能病种库和肺癌多学科智能诊断系统,并在FRVT测试中蝉联冠军。2019年5月,依图发布全球首款深度学习云端定制SoC芯片,从设计到制造实现全面国产化,拥有自主知识产权,性能远超对标的NVIDIA;自发布之日起即实现交付商用。依图被美国财经媒体CNBC纳入2019年度“全球最具颠覆性企业50强”。

? ? ?2020年2月5日,工信部科技司发文倡议:充分发挥人工智能赋能效用、协力抗击疫情。依图积极响应,利用技术优势,快速研发多套AI系统为疫情防控提供技术支撑。其中,“新冠肺炎智能评价系统”是业内首款智能评估新型冠状病毒性肺炎的AI影像产品。采用创新的人工智能全肺定量分析技术,为临床专家提供基于CT影像的智能化新型冠状病毒性病灶定量分析及疗效评价等服务。系统可在2-3秒之内完成分析,极大提升了医生诊断效率,已在武汉协和医院、武汉大学中南医院、武汉大学人民医院、荆州市第一人民医院等几十家公共医疗机构完成部署。2月9日央视新闻联播对“新冠肺炎智能评价系统”在武汉协和等三所医院临床使用、为医生决策提供依据的事迹进行了专门报到。

? ? ?“依图科技”在人工智能安防、智慧医疗、智慧城市管理等多个领域已是公认的领跑者,与华润集团、中国诚通在商业物管、医药医疗、芯片设计制造、金融投资、智能制造等多业务板块有着广泛的协作空间。

? ? ?作为华润集团、中国诚通科技投资的重要抓手,“润诚产业领航基金”践行央企使命职责,秉承“世界一流技术+中国落地故事”的投资策略,持续面向全球广泛搜寻先进技术,探索中国业务落地;扶持中国自主创新的世界级高科技企业做大做强,助力“中国制造”向“中国创造”升级转型!

When the world is suffering impact from Coronavirus, CR-CCTIndustry Pilot Fund undertook efforts to perform daily duty as before.Recently, CR-CCT Industry Pilot Fund, co-managed by China Resources Capital Managementand China Chengtong (HK), overcame a series of unexpected difficulties tocomplete a US$30 million investment in the world-class artificial intelligencecompany Yitu Technology. The fund will continuously target high-techcompanies to create synergies for parent groups and assist invested companieswith original world-leading technology to industrialize and scale up.

Yitu is a world-class artificial intelligence company that hasgrown up entirely based on its independent research and original developedtechnology. It is a national new generation artificial intelligence innovationplatform and a key participant in “Shanghai Key Laboratory of ArtificialIntelligence for Medical Image and Knowledge Graph”. The company mainly adoptscomputer vision, natural language processing and chip design to providecomprehensive artificial intelligence solutions in various applicationscenarios. As one of the innovation pioneers in artificial intelligenceindustry, the company combines advanced artificial intelligence technology withindustrial applications in the public security, health care, finance, retail,and chip development industries, which has been widely recognized and praisedby customers.

The company has repeatedly won the first place in various domesticand international authority competitions. Yitu is the only enterprise in theworld that has won two world champions in face recognition for threeconsecutive times, namely, NIST and IARPA. In the latest face recognitioncompetition (FRVT) organized by NIST in 2018, according to the graph algorithm,it won the toppest place, far surpassing other technology companies. In May2019, the company released the worlds first deep learning cloud basecustomized SoC chip, achieving full domestication from design to manufacturing,with independent intellectual property rights and performance far surpassedNVIDIA in processing speed and power consumption. The chip has been deliveredcommercially as of the date of release. Yitu was among the list of Top 50Most Disruptive Companies in the World by the US financial media CNBC in2019.

Yitu responded quickly to the outbreak of Coronavirus and utilizedits technological advantages to rapidly develop multiple AI systems to providetechnical support for epidemic prevention and control. The “CoronavirusIntelligent Evaluation System” is the first AI imaging product in the industryto intelligently evaluate the disease. It uses Innovative artificial lungquantitative analysis technology to provide clinical experts with infection andfocal quantitative analysis and curative effect evaluation services based on CTimages. The system can complete the analysis in 2-3 seconds, which greatlyimproves the diagnosis efficiency. It has been installed in dozens of publicmedical institutions such as Wuhan Union Hospital, Wuhan University ZhongnanHospital, Wuhan University Peoples Hospital, Jingzhou First Peoples Hospital,etc. On February 9th, CCTV News reported on the positive use of theCoronavirus Intelligent Evaluation System in three hospitalsincluding Wuhan Xiehe from the perspective of providing basis for doctorsdecisions.

CR-CCT Industry Pilot Fund strives to find world class technologycompanies at growth stage with proven track record and business model. Investedcompanies obtains support from various aspects for their business launch inGreat China Area and the fund, at the same time, achieve high double digitreturn for investors. In line with the above investment strategy, YituTechnology has been well recognized as a leader in artificialintelligence public security, smart health care and smart city managementindustries. There exist huge potentials and synergies in its cooperation withthe fund. CR-CCT Industry Pilot Fund will continuously support world-classhigh-tech enterprises with independent innovation and launch in China to createa win-win situation for both investors and target companies.